Trial Profile

Phase 2a dose ranging clinical trial of ADS05 in patients with ulcerative colitis

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 07 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ADS 051 (Primary)
Indications Ulcerative colitis
Focus Adverse reactions

Most Recent Events

05 Dec 2023 According to an Adiso Therapeutics media release, this study will be conducted globally and begin recruiting in 2024.
22 Oct 2023 According to an Adiso Therapeutics media release, based on positive topline results from SCOUT study company has recently completed positive end-of-Phase 1 FDA interaction, and planning to advance ADS051 in a Phase 2 clinical study in early 2024.
14 Jul 2023 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com